ADTX News and Press, ADiTx Therapeutics Inc. From 08/05/22

Most kidney transplant patients usually stop taking their immunosuppressive drugs before starting cancer immunotherapy treatment to diminish the chances of their immune systems attacking the transplanted organs. However, a new study has found that combining standard antirejection medication ...

Biotech innovation company, Aditxt, Inc (“Aditxt” or the “Company”) is developing and commercializing technologies focused on monitoring and reprogramming the immune system  BULLTheir ground-breaking ADi(TM) immune reprogramming platform will be initiall...

Aditxt (NASDAQ: ADTX) was featured in the Bell2Bell Podcast , a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels. Amro Albanna, co-founder, chairman and CEO of Aditxt, joined the latest episode ...

LOS ANGELES, Aug. 02, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bel...

New research has shown that allowing infants to taste foods that contain wheat, milk, eggs and peanuts as early as the age of three months may decrease an infant’s risk of developing a food allergy. The study, which was led by Professor Karin C. Lødrup Carlsen of the Institute ...

UT Southwestern researchers recently reported that they had used cryoelectron microscopy to obtain the image of an auto-antibody that had bound itself to the surface receptor of a nerve cell. This discovery shows the mechanism behind neurological autoimmune illnesses and may be useful in t...

Aditxt (NASDAQ: ADTX) provides the AditxtScore(TM), a proprietary immune mapping technology designed to provide a personalized profile of the immune system. “Licensed from Stanford University, AditxtScore(TM) for COVID-19 is Aditxt’s first commercial product. It enables patie...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Aditxt , Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI -100 ” Aditxt, Inc. (NASDAQ: ADTX) ...

3 Hot Penny Stocks to Add to Your July Watchlist Finding penny stocks to buy right now can be challenging. But, with trading mostly flat today and bullish price action this week, there is a lot for investors to know. If you’re thinking about buying penny stocks, you have to consi...

Gainers: Seritage Growth Properties ( SRG ) +72% . Aditxt ( ADTX ) +70% . Humanigen ( HGEN ) +35% . Clovis Oncology ( CLVS ) +30% . MyMD Pharmaceuticals ( MYMD ) +27% . Oramed Pharmaceuticals ( ORMP ) +26% . Kura ...